8/21/2020 0 Comments Coronavirus update: Europe, UK strike vaccine deals; antibody therapies on the riseThree of the frontrunners in the global coronavirus vaccine race announced Friday deals for hundreds of millions of doses with European countries, which will add to the demand on an already strained supply chain as the global pandemic rages on. Johnson and Johnson (JNJ) struck a deal for 30 million doses with the U.K. and is collaborating on a Phase 3 trial. The company is also in talks with the European Union to provide 200 million doses. Meanwhile, AstraZeneca (AZN) announced a deal for 400 million doses, and Novavax (NVAX) struck a deal for 60 million doses with the U.K. that also includes collaboration on a Phase 3 trial. By comparison, these same companies have promised 100 million doses (J&J and Novavax, each) and 300 million doses (AstraZeneca) to the U.S. All are in various stages of clinical trials, with AstraZeneca leading with its partnership with Oxford University. ... Read more here : https://sports.yahoo.com/coronavirus-update-europe-uk-strike-vaccine-deals-antibody-therapies-on-the-rise-165032480.html
0 Comments
Antibodies could create immunity even before we get a vaccine.
by Antonio Regalado August 3, 2020Nurses and patients in some US assisted living facilities will receive an antibody drug to prevent covid-19 infection, according to drug company Eli Lilly. The drug: Early in the coronavirus pandemic, companies searched the blood of covid-19 survivors for potent antibodies against the novel virus. Eli Lilly’s drug is one of these Y shaped proteins—it’s a natural antibody manufactured at larger scale. The trial: To carry out the study, which will involve 2,400 people, Lilly will work with the National Institutes of Health to target nursing homes with covid-19 outbreaks. In some areas, elderly residents in nursing homes account for the majority of covid-19 deaths. How it works: Just like natural antibodies, Lilly’s antibody should grab onto the virus and block it. Similar antibody treatments proved effective in treating Ebola disease, but the goal here is to prevent infection by giving the drugs earlier. Prevention with antibodies is known to work. There is an antibody shot given to babies that prevents RSV, a respiratory infection striking newborns. ... Read more here : https://www.technologyreview.com/2020/08/03/1005946/eli-lilly-is-testing-a-way-to-prevent-covid-19-thats-not-a-vaccine/ 8/11/2020 0 Comments GOP Congressman Plans Bill to Speed Up Pandemic Responses, Says Health System 'Caught Flat-footed'Measures to quicken the response to viruses and pathogens with pandemic potential will be laid out to Congress in an act to be introduced by Rep. Paul Gosar (R-AZ).
Gosar, speaking exclusively with Newsweek, said he plans to put forward the bill following the August recess. The proposed legislation would direct the secretary of defense to "carry out a program for the development of rapid and cost-effective medical countermeasures to pandemics." They would be directed to designate a lead within the Department of Defense to implement such a program. The act lays out objectives for actions to be taken upon the discovery of a "virus or other pathogen that may cause pandemic" within 60 days but with a goal to reduce this to 28. These targets would include growing the virus or pathogen in order to identify an antibody or other biological product to target it as part of a "medical counter measure." The aim would then be to develop this to then deliver it to patients within days. ... Read more here : https://www.newsweek.com/pandemic-response-covid-19-coronavirus-rapid-bill-1521934 Learn about a new model for public health during pandemics, as well as Passive Immunity from expert thought leaders in biodefense, politics, sports, and media. Register at theabiforum.org
About this EventJoin CBS News Homeland Security Correspondent Jeff Pegues, Congressman Paul Gosar, The New Orleans Saints all-time leading wide receiver Marques Colston, Executive Director of American BioDefense Institute Dr. Ravi Starzl, Attorney and Veteran advocate John Berry, and IP strategist JiNan Glasgow George for a one of a kind forum hosted by The American BioDefense Institute. Five months ago our health system was put to the test – and was found wanting. All around the globe, hospitals were overwhelmed, and leaders had to cope with an unprecedented and sudden impact on society. In the U.S. alone there have been over 150,000 deaths, tremendous unemployment, and major interruptions in many aspects of American life including business, law, and sports. During the American BioDefense Institute forum, you’ll hear about a new model for public health that can interrupt the current pandemic, while ensuring our health system and society are better prepared for future threats. This symposium will provide expert data from thought leaders on how the pandemic has influenced sports, law, and business, as well as scientific research dedicated to addressing America’s BioDefense. This forum is moderated by the great Jeff Pegues, CBS News Homeland Security Correspondent, featuring: • Congressman Dr. Paul Gosar who will be discussing the latest Congress is doing regarding the pandemic • Dr. Ravi Starzl will dialogue about a new public health model and explain the concept of passive immunity • Marques Colston, the New Orleans Saints all-time leading wide receiver and creator of Columbia Business School’s Executive education program for current and retired NFL players • Attorney John Berry will demonstrate changes to the legal system. • JiNan Glasgow George who will specifically address the pandemic’s influence on American Competitiveness Don’t miss this historical opportunity to hear these great minds work together and address such a vital, immediate, and necessary topic. Register at theabiforum.org Click here for more : https://americanbiodefenseinstitute.org/developing-a-new-model-for-public-health-during-pandemics/ |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |